Nivolumab/pembrolizumabPneumonia: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1846卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92491-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：243 / 243

相关论文

共 50 条

[1] PembrolizumabPneumonia: case report
Reactions Weekly, 2022, 1900 (1) : 275 - 275
[2] PembrolizumabPneumonia and hepatitis: case report
Reactions Weekly, 2023, 1972 (1) : 294 - 294
[3] PembrolizumabPneumonia and acute uncomplicated diverticulitis: case report
Reactions Weekly, 2023, 1971 (1) : 219 - 219
[4] Ipilimumab/nivolumab/Nivolumab/Nivolumab/relatlimabVarious toxicities: case report
Reactions Weekly, 2025, 2056 (1) : 265 - 265
[5] Nivolumab/vemurafenibVitiligo: case report
Reactions Weekly, 2017, 1656 (1) : 365 - 365
[6] Nivolumab/pembrolizumabThyroiditis: case report
Reactions Weekly, 2024, 2039 (1) : 444 - 444
[7] Ipilimumab/nivolumab/nivolumab/prednisoneVarious toxicities: case report
Reactions Weekly, 2023, 1963 (1) : 305 - 305
[8] Nivolumab/prednisoloneHyperthyroidism: case report
Reactions Weekly, 2017, 1666 (1) : 228 - 228
[9] Nivolumab/pembrolizumabHypothyroidism: case report
Reactions Weekly, 2022, 1930 (1) : 448 - 448
[10] Nivolumab/relatlimabCholangitis: case report
Reactions Weekly, 2021, 1847 (1) : 364 - 364

← 1 2 3 4 5 →